ARTICLE | Management Tracks
IDRx names Clackson, Dahms to C-suite and Auspitz chair
Plus: new COO for radiopharma Telix, and updates from Rigel, Venatorx and Capsida
March 13, 2024 1:09 AM UTC
Cancer company IDRx Inc. named Tim Clackson CEO, Brad Dahms CFO and CBO, and Ben Auspitz chair. Clackson was CEO of Theseus Pharmaceuticals Inc. and succeeds Auspitz, who co-founded IDRx; Dahms also joins from Theseus, where he was CFO.
Australian radiopharmaceuticals company Telix Pharmaceuticals Ltd. (ASX:TLX) named Darren Patti as group COO. Patti joined Telix in March 2021 as COO, Americas...